Anticipated Data and Practice-Changing Trials: An ASCO 2026 Breast Cancer Preview

The upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting is poised to showcase pivotal data that could reframe treatment paradigms across the breast cancer spectrum, from early-stage de-escalation strategies to novel therapeutics for advanced disease. Ahead of the meeting, MinhTri Nguyen, MD, and Nerea Lopetegui, MD, shared their insights with CancerNetwork® on the specific clinical trials, regulatory debates, and emerging modalities generating the most significant professional anticipation.